Since its introduction to the market in 2012, Unyvero has been brought into numerous hospital laboratories and intensive care units throughout Europe. Leading clinical experts have tested the system and now appreciate the advantages of the Unyvero Solution in everyday clinical use.
Curetis Publishes Business and Financial Update for the First Nine Months of 2017
Curetis initiates U.S. FDA study for Unyvero Invasive Joint Infections Cartridge
37ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse - Paris, France - December 18 to 19, 2017
Reanimation Congress 2018 - Paris, France - 24 to 26 January, 2018